Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
25 participants
INTERVENTIONAL
2013-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
TReatment of Atrial Fibrillation With Dual dEfibrillator in Heart Failure Patients
NCT00345592
Safety and Effectiveness of Cardiac Resynchronization Therapy With Defibrillation
NCT00387803
Precision Event Monitoring for Patients With Heart Failure Using HeartLogic
NCT03579641
Assessment of Pacing Stimulus Conduction and Latency Measurements in CRT-D Patients
NCT03314675
Evaluation of Left Ventricular Autothreshold, Phase Two
NCT01242722
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Diaphragmatic stimulation
Diaphragmatic stimulation via electrode for 4 weeks
Diaphragmatic stimulation
No intervention
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diaphragmatic stimulation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Reduced left ventricular ejection fraction (LVEF) \<35%
* Guideline-recommended drug therapy
Exclusion Criteria
* Life expectancy presumably \<1 year
* Pregnancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Luzerner Kantonsspital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Paul Erne
Head of Department of Cardiology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Paul Erne, MD
Role: PRINCIPAL_INVESTIGATOR
Luzerner Kantonsspital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Luzerner Kantonsspital
Lucerne, Canton of Lucerne, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
13008
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.